Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV).

Passage of the prototypic arenavirus lymphocytic choriomenigitis virus (LCMV) in cultured cells in the presence of the mutagenic agent 5-fluorouracil (FU) resulted in efficient and systematic virus extinction under conditions that did not significantly affect cell survival. FU-mediated extinction of LCMV was associated with 3.6- to 10-fold increases in the mutation frequencies for the three viral genes examined, but with only very modest effects on virus replication and transcription during a single round of infection. Likewise, FU did not affect expression of a LCMV minigenome. In contrast, the well documented antiviral effect of ribavirin against LCMV was not associated with significant increases in virus mutation frequencies, but rather with a dramatic inhibition of both viral RNA synthesis and LCMV minigenome expression. Mutagen induced viral extinction has been recently reported for positive strand RNA viruses polio and foot-and-mouth disease, and the lentivirus HIV-1. Our findings indicate that lethal mutagenesis can be effective also against LCMV, a negative strand RNA virus. Moreover, FU treatment prevented the establishment of LCMV persistent infection in mice deficient in B and T cells, suggesting the feasibility in vivo of lethal mutagenesis as a novel antiviral strategy.

[1]  A. Anusz [Lassa fever]. , 1981, Pielegniarka i polozna.

[2]  C. Peters Human infection with arenaviruses in the Americas. , 2002, Current topics in microbiology and immunology.

[3]  R. Lanford,et al.  Ribavirin Induces Error-Prone Replication of GB Virus B in Primary Tamarin Hepatocytes , 2001, Journal of Virology.

[4]  Stuart T. Nichol,et al.  Genetic Diversity among Lassa Virus Strains , 2000, Journal of Virology.

[5]  C. Peters,et al.  Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. , 1997, Molecular phylogenetics and evolution.

[6]  F. Fuller-Pace,et al.  Detection of virus-specific RNA-dependent RNA polymerase activity in extracts from cells infected with lymphocytic choriomeningitis virus: in vitro synthesis of full-length viral RNA species , 1989, Journal of virology.

[7]  N. Snell Ribavirin - current status of a broad spectrum antiviral agent , 2001, Expert opinion on pharmacotherapy.

[8]  Pedro R. Lowenstein,et al.  Response of Foot-and-Mouth Disease Virus to Increased Mutagenesis: Influence of Viral Load and Fitness in Loss of Infectivity , 2000, Journal of Virology.

[9]  L. De,et al.  Detection of Borna disease virus (BDV) antibodies and BDV RNA in psychiatric patients: evidence for high sequence conservation of human blood-derived BDV RNA , 1996, Journal of virology.

[10]  R. Eritja,et al.  Ionization of bromouracil and fluorouracil stimulates base mispairing frequencies with guanine. , 1993, The Journal of biological chemistry.

[11]  J. Holland Genetic Diversity of RNA Viruses , 2011, Current Topics in Microbiology and Immunology.

[12]  E. Domingo,et al.  RNA virus mutations and fitness for survival. , 1997, Annual review of microbiology.

[13]  E. Domingo,et al.  Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase. , 1992, Gene.

[14]  C. Cameron,et al.  RNA virus error catastrophe: Direct molecular test by using ribavirin , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Eigen,et al.  Natural selection: a phase transition? , 2000, Biophysical chemistry.

[16]  R. K. Robins,et al.  Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses , 1984, Antimicrobial Agents and Chemotherapy.

[17]  M Aguet,et al.  Functional role of type I and type II interferons in antiviral defense. , 1994, Science.

[18]  Katherine Spindler,et al.  Rapid evolution of RNA genomes. , 1982, Science.

[19]  M. Salvato,et al.  Biochemical and immunological evidence that the 11 kDa zinc-binding protein of lymphocytic choriomeningitis virus is a structural component of the virus. , 1992, Virus research.

[20]  A. Ghosh,et al.  Inhibition of replication of rinderpest virus by 5-fluorouracil. , 1996, Antiviral research.

[21]  David A. Steinhauer,et al.  Mutation Frequencies at Defined Single Codon Sites in Vesicular Stomatitis Virus and Poliovirus Can Be Increased Only Slightly by Chemical Mutagenesis , 1990, Journal of virology.

[22]  K. Campbell,et al.  Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. , 1998, Science.

[23]  E. Domingo,et al.  Contribution of LCMV towards deciphering biology of quasispecies in vivo. , 2002, Current topics in microbiology and immunology.

[24]  E. Domingo,et al.  Origin and Evolution of Viruses , 2010, Virus Genes.

[25]  C. Pringle Genetic Characteristics of Conditional Lethal Mutants of Vesicular Stomatitis Virus Induced by 5-Fluorouracil, 5-Azacytidine, and Ethyl Methane Sulfonate , 1970, Journal of virology.

[26]  J. Mullins,et al.  Lethal mutagenesis of HIV with mutagenic nucleoside analogs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Drake,et al.  Mutation rates among RNA viruses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  E. Domingo,et al.  Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy , 1995, Journal of virology.

[29]  P. Schuster,et al.  Nature and Evolution of Early Replicons , 1998 .

[30]  V. Stollar,et al.  Sindbis virus mutants resistant to mycophenolic acid and ribavirin. , 1987, Virology.

[31]  Lin Chao,et al.  Fitness of RNA virus decreased by Muller's ratchet , 1990, Nature.

[32]  L. De,et al.  Selective disruption of growth hormone transcription machinery by viral infection. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[33]  B. Meyer,et al.  Arenaviruses: genomic RNAs, transcription, and replication. , 2002, Current topics in microbiology and immunology.

[34]  M. Oldstone,et al.  The primary structure of the lymphocytic choriomeningitis virus L gene encodes a putative RNA polymerase. , 1989, Virology.

[35]  K. Borden,et al.  The Lymphocytic Choriomeningitis Virus RING Protein Z Associates with Eukaryotic Initiation Factor 4E and Selectively Represses Translation in a RING-Dependent Manner , 2000, Journal of Virology.

[36]  J. Huggins,et al.  Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever , 1988, Antimicrobial Agents and Chemotherapy.

[37]  P. Borrow,et al.  Receptor structure, binding, and cell entry of arenaviruses. , 2002, Current topics in microbiology and immunology.

[38]  E. Domingo,et al.  Efficient Virus Extinction by Combinations of a Mutagen and Antiviral Inhibitors , 2001, Journal of Virology.

[39]  M. Buchmeier,et al.  Arenaviridae: The viruses and their replication , 2001 .

[40]  J. C. de la Torre,et al.  RING Finger Z Protein of Lymphocytic Choriomeningitis Virus (LCMV) Inhibits Transcription and RNA Replication of an LCMV S-Segment Minigenome , 2001, Journal of Virology.

[41]  M. Salvato Molecular Biology of the Prototype Arenavirus, Lymphocytic Choriomeningitis Virus , 1993 .

[42]  J. Huggins Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. , 1989, Reviews of infectious diseases.

[43]  J. Arnold,et al.  The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen , 2000, Nature Medicine.

[44]  M. Salvato,et al.  The completed sequence of lymphocytic choriomeningitis virus reveals a unique RNA structure and a gene for a zinc finger protein. , 1989, Virology.

[45]  F. Alt,et al.  Restoration of T cell development in RAG-2-deficient mice by functional TCR transgenes. , 1993, Science.

[46]  P. Pandolfi,et al.  Role of the Promyelocytic Leukemia Protein PML in the Interferon Sensitivity of Lymphocytic Choriomeningitis Virus , 2001, Journal of Virology.

[47]  J. C. de la Torre,et al.  NP and L Proteins of Lymphocytic Choriomeningitis Virus (LCMV) Are Sufficient for Efficient Transcription and Replication of LCMV Genomic RNA Analogs , 2000, Journal of Virology.

[48]  C. Lucchinetti,et al.  5-Fluorouracil and Levamisole Exacerbate Demyelination in Susceptible Mice Infected with Theiler's Virus , 1997, Experimental Neurology.

[49]  C. Pringle,et al.  Measurement of surface antigen by specific bacterial adherence and scanning electron microscopy (SABA/SEM) in cells infected by vesiculovirus ts mutants. , 1982, The Journal of general virology.

[50]  P. Schuster,et al.  Self-replication with errors. A model for polynucleotide replication. , 1982, Biophysical chemistry.

[51]  P. Borrow,et al.  A single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with the ability to cause growth hormone deficiency syndrome , 1996, Journal of virology.

[52]  F. Alt,et al.  Function and Control of Recombination‐Activating Gene Activity a , 1992, Annals of the New York Academy of Sciences.

[53]  W. Ebeling,et al.  Physical Approaches to Biological Evolution , 1995 .

[54]  V. Stollar,et al.  Mutations that confer resistance to mycophenolic acid and ribavirin on Sindbis virus map to the nonstructural protein nsP1. , 1991, Virology.

[55]  Y. Cheng,et al.  Metabolism and mechanism of action of 5-fluorouracil. , 1990, Pharmacology & therapeutics.

[56]  A. Kentsis,et al.  The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E. , 2001, Journal of molecular biology.